ACB
ACB
NASDAQ · Pharmaceuticals

Aurora Cannabis Inc

$2.93
+0.01 (+0.34%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +590.1% upside
Low Target $15.45
Average Target $20.22
High Target $24.58
Current Price $2.93
Current
$2.93
Target
$20.22
$15.45 $20.22 avg $24.58
Scenario Analysis
Bear Case
$15.45
427.3%
Low target
Base Case
$20.22
+590.1%
Avg target
Bull Case
$24.58
+738.9%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$9.33
-68.6% from high
52-Week Low
$3.77
+-22.3% from low
Target vs 52W High
$20.22
+116.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%